The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of operability classifications to predict outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy.
Ching-Wei David Tzeng
No relevant relationships to disclose
Jason B. Fleming
No relevant relationships to disclose
Jeffrey Edwin Lee
No relevant relationships to disclose
Lianchun Xiao
No relevant relationships to disclose
Peter W. T. Pisters
No relevant relationships to disclose
Jean-Nicolas Vauthey
No relevant relationships to disclose
Eddie K. Abdalla
No relevant relationships to disclose
Robert A. Wolff
No relevant relationships to disclose
Gauri R. Varadhachary
No relevant relationships to disclose
David R. Fogelman
No relevant relationships to disclose
Christopher H. Crane
No relevant relationships to disclose
Aparna Balachandran
No relevant relationships to disclose
Matthew H.G. Katz
No relevant relationships to disclose